Grant of options and PDMR dealings

MicroSalt

13/02/2026 07:00

RNS Number : 8623S

MicroSalt PLC

13 February 2026

 

13 February 2026

MicroSalt Plc

("MicroSalt" or the "Company")

Grant of Options and PDMR Dealings

MicroSalt plc (AIM:SALT), a leading provider of full-flavour, natural salt with approximately 50% less sodium, announces that it has granted options over 575,000 ordinary shares of £0.001625 each in the Company ("Ordinary Shares") (the "Options") under the Company's 2024 Long Term Incentive Plan (the "2024 LTIP"). The Options have been granted to certain directors and other PDMRs of the Company as follows:

Subscriber
No. Share Options granted
Rick Guiney
CEO
250,000
Gary Urmston
Interim CFO
50,000
Javier Contreras
COO
75,000
Mario Habre
Business development director
100,000
Carolina Berardi
VP of marketing
50,000
Stephanie Chavez
VP of finance
50,000
TOTAL
575,000

 

Subject to satisfaction of the acceptance conditions under the 2024 LTIP, the Options will vest, subject to the achievement of certain revenue performance conditions for the financial years ending 31 December 2026 and 2027, over a 2 year period from 31 December 2025, and lapse on the tenth anniversary of grant. The exercise price of the Options is £0.45, being the issue price of the Company's recent equity fundraise.

 

The new Options (if all are accepted), together with other options already granted, represent approximately 11.8% of the current issued share capital of the Company.

 

For further information, please contact:

MicroSalt plc
info@microsaltinc.com
Rick Guiney (CEO)
Zeus(Nominated Adviser and Broker)
+44 (0)20 3829 5000
David Foreman / James Edis (Investment Banking)
Dom King (Corporate Broking) / Rupert Woolfenden (Sales)
Gracechurch Group(Financial PR)
+44 (0)20 4582 3500
Heather Armstrong, Alexis Gore, Rebecca Scott


 

Further information on the Company can be found on its website at: www.microsaltinc.co

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Further details are set out in the below notification, made in accordance with the requirements of the UK Market Abuse Regulation. 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1
Details of the person discharging managerial responsibilities/person closely associated
a.
Name
(i) Rick Guiney
(ii) Gary Urmston
(iii) Javier Contreras
(iv) Mario Habre
(v) Carolina Berardi
(vi) Stephanie Chavez
2
Reason for notification
a.
Position/Status
(i) CEO
(ii) Interim CFO
(iii) COO
(iv) Business development director
(v) VP of marketing
(vi) VP of finance
b.
Initial notification/
Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
MicroSalt plc
b.
LEI
213800L7WRHP8CCEEQ48
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument

 Identification Code
Ordinary Shares of £0.001625 each
ISIN: GB00BQB6FF85
b.
Nature of the transaction
Grant of options
c.
Price(s) and volume(s)
Price(s)
Volume(s)
(i)
£0.45
250,000
(ii)
£0.45
50,000
(iii)
£0.45
75,000
(iv)
£0.45
100,000
(v)
£0.45
50,000
(vi)
£0.45
50,000
d.
Aggregated information
See above
e.
Date of the transactions
29 January 2026
f.
Place of the transaction
London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHGPUBWPUPQPWP